Aeroflox Plus

AEROFLOX-PLUS Tablets – Ofloxacin, Ornidazole & Lactic Acid Bacillus

AEROFLOX-PLUS is a combination formulation containing Ofloxacin 200 mg, Ornidazole 500 mg and Lactic Acid Bacillus 120 Million Spores.

Ofloxacin is a fluoroquinolone antibacterial agent, while Ornidazole is a nitroimidazole antimicrobial active against susceptible anaerobic bacteria and certain protozoa. Lactic Acid Bacillus is included as a probiotic component intended to support intestinal microbial balance.

This formulation combines antibacterial, antiprotozoal and probiotic components in a single tablet. Its use should be guided by a qualified healthcare professional based on the patient's clinical condition and the likely or confirmed causative organisms.

Available from Aerochem Neutron for pharmaceutical distribution

• Triple-component formulation: Combines Ofloxacin 200 mg, Ornidazole 500 mg and Lactic Acid Bacillus 120 Million Spores.

• Antibacterial activity: Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV in susceptible organisms.

• Antiprotozoal and anaerobic coverage: Ornidazole acts against susceptible protozoa and anaerobic microorganisms.

• Probiotic component: Lactic Acid Bacillus is included to help support intestinal microbial balance.

• Tablet dosage form: Provides three components in a single oral formulation.

• Prescription-based use: Intended for use only when clinically appropriate and prescribed by a registered medical practitioner.

Potential Clinical Applications

• Selected bacterial and protozoal gastrointestinal infections where the combination is clinically appropriate.

• Suspected or confirmed mixed infections involving susceptible microorganisms, where combination therapy is justified.

• Other indications specifically supported by the product's approved prescribing information.

Use only under medical supervision. Fluoroquinolones such as Ofloxacin carry important safety warnings and should be prescribed following an individual benefit-risk assessment.